Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model

被引:180
作者
Du, Heng [1 ,2 ]
Guo, Lan [1 ,2 ]
Zhang, Wensheng [1 ,2 ,3 ]
Rydzewska, Monika [1 ,2 ]
Yan, Shidu [1 ,2 ,4 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[3] Beijing Normal Univ, Inst Nat Med & Chinese Med Resources, Beijing 100875, Peoples R China
[4] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
关键词
Alzheimer's disease; Amyloid beta; Mitochondrial permeability transition pore; Cyclophilin D; AMYLOID-BETA-PEPTIDE; CYTOCHROME-C-OXIDASE; NEURONAL CELL-DEATH; A-BETA; PERMEABILITY TRANSITION; OXIDATIVE STRESS; METABOLIC DYSFUNCTION; IN-VIVO; CALCIUM; MICE;
D O I
10.1016/j.neurobiolaging.2009.03.003
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Mitochondrial stress is one of the early features of Alzheimer disease (AD). Mitochondrial A beta has been linked to mitochondrial toxicity. Our recent study demonstrated that cyclophilin D (CypD) mediated mitochondrial permeability transition pore (mPTP) is an important mechanism for neuronal and synaptic stress induced by both A beta and oxidative stress. In transgenic AD-type mice overexpressing mutant amyloid precursor protein (APP) and A beta (mAPP), CypD deficiency improves mitochondrial and synaptic function and learning/memory up to 12 months old. Here we provide evidence of the protective effects of CypD deficiency in aged AD mice (22-24 months). Cyp D deficient mAPP mice demonstrate less calcium-induced mitochondrial swelling, increased mitochondrial calcium uptake capacity, preserved mitochondrial respiratory function and improved spatial learning/memory even in old age (known to be the age for late stage AD pathology and synaptic dysfunction). These data demonstrate that abrogation of CypD results in persistent life-long protection against A beta toxicity in an Alzheimer's disease mouse model, thereby suggesting that blockade of CypD may be of benefit for Alzheimer disease treatment. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:398 / 406
页数:9
相关论文
共 39 条
[21]  
Jordán J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878
[22]   Amyloid β induces neuronal cell death through ROS-mediated ASK1 activation [J].
Kadowaki, H ;
Nishitoh, H ;
Urano, F ;
Sadamitsu, C ;
Matsuzawa, A ;
Takeda, K ;
Masutani, H ;
Yodoi, J ;
Urano, Y ;
Nagano, T ;
Ichijo, H .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (01) :19-24
[23]   Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo [J].
Kaminsky, Yury G. ;
Kosenko, Elena A. .
FREE RADICAL RESEARCH, 2008, 42 (06) :564-573
[24]   ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease [J].
Lustbader, JW ;
Cirilli, M ;
Lin, C ;
Xu, HW ;
Takuma, K ;
Wang, N ;
Caspersen, C ;
Chen, X ;
Pollak, S ;
Chaney, M ;
Trinchese, F ;
Liu, SM ;
Gunn-Moore, F ;
Lue, LF ;
Walker, DG ;
Kuppusamy, P ;
Zewier, ZL ;
Arancio, O ;
Stern, D ;
Yan, SSD ;
Wu, H .
SCIENCE, 2004, 304 (5669) :448-452
[25]   Amyloid β-peptide induces apoptosis-related events in synapses and dendrites [J].
Mattson, MP ;
Partin, J ;
Begley, JG .
BRAIN RESEARCH, 1998, 807 (1-2) :167-176
[26]   Aβ42 is essential for parenchymal and vascular amyloid deposition in mice [J].
McGowan, E ;
Pickford, F ;
Kim, J ;
Onstead, L ;
Eriksen, J ;
Yu, C ;
Skipper, L ;
Murphy, MP ;
Beard, J ;
Das, P ;
Jansen, K ;
DeLucia, M ;
Lin, WL ;
Dolios, G ;
Wang, R ;
Eckman, CB ;
Dickson, DW ;
Hutton, M ;
Hardy, J ;
Golde, T .
NEURON, 2005, 47 (02) :191-199
[27]   High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition [J].
Naga, Kranthi Kumari ;
Sullivan, Patrick G. ;
Geddes, James W. .
JOURNAL OF NEUROSCIENCE, 2007, 27 (28) :7469-7475
[28]   Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death [J].
Nakagawa, T ;
Shimizu, S ;
Watanabe, T ;
Yamaguchi, O ;
Otsu, K ;
Yamagata, H ;
Inohara, H ;
Kubo, T ;
Tsujimoto, Y .
NATURE, 2005, 434 (7033) :652-658
[29]  
Ohta S, 2006, J ALZHEIMERS DIS, V9, P155
[30]  
Paradis E, 1996, J NEUROSCI, V16, P7533